0001628280-20-014320.txt : 20201006 0001628280-20-014320.hdr.sgml : 20201006 20201006073632 ACCESSION NUMBER: 0001628280-20-014320 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201005 FILED AS OF DATE: 20201006 DATE AS OF CHANGE: 20201006 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bridger Gary CENTRAL INDEX KEY: 0001600049 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38295 FILM NUMBER: 201225578 MAIL ADDRESS: STREET 1: C/O FIVE CORNERS CAPITAL STREET 2: 700 WEST GEORGIA STREET, SUITE 2500 CITY: VANCOUVER STATE: A1 ZIP: V7Y 1B3 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: X4 Pharmaceuticals, Inc CENTRAL INDEX KEY: 0001501697 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 273181608 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 61 NORTH BEACON STREET STREET 2: 4TH FLOOR CITY: BOSTON STATE: MA ZIP: 02134 BUSINESS PHONE: 857-529-8300 MAIL ADDRESS: STREET 1: 61 NORTH BEACON STREET STREET 2: 4TH FLOOR CITY: BOSTON STATE: MA ZIP: 02134 FORMER COMPANY: FORMER CONFORMED NAME: Arsanis, Inc. DATE OF NAME CHANGE: 20100920 4 1 wf-form4_160198417729837.xml FORM 4 X0306 4 2020-10-05 0 0001501697 X4 Pharmaceuticals, Inc XFOR 0001600049 Bridger Gary C/O X4 PHARMACEUTICALS, INC. 61 NORTH BEACON STREET, 4TH FLOOR BOSTON MA 02134 1 0 0 0 Stock Option (right to buy) 7.33 2020-10-05 4 A 0 30000 0 A 2030-10-04 Common Stock 30000.0 30000 D 33.3333% of the shares subject to the option shall vest on October 5, 2021, with the remainder vesting in equal monthly installments of 2.7777% of the shares subject to the option until the 36-month anniversary of the date of the grant, subject to the Reporting Person's continued services as a director through each applicable vesting date. Derek M. Meisner, attorney-in-fact 2020-10-06